0
Rhythm Pharmaceuticals, Inc.
- 51-200 Employees
- Based in Boston, Massachusetts
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. Rhythm’s lead product candidate is setmelanotide, a first-in-class melanocortin-4 receptor (MC4R) agonist. Rhythm supports The Genetic Obesity Project (GeneticObesity.com) and the GO-ID Genotyping Study (GeneticObesityID.com).
Rhythm Pharmaceuticals, Inc.
Most Recent Responsibility Report
Report Locked. Rhythm Pharmaceuticals, Inc. has reached its limit for free report views.
Rhythm Pharmaceuticals, Inc. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
Our service enables potential investors to review the most recent and archived Rhythm Pharmaceuticals, Inc. Sustainability Report, Rhythm Pharmaceuticals, Inc. Corporate Social Responsibility Report, Rhythm Pharmaceuticals, Inc. CSR Report, Rhythm Pharmaceuticals, Inc. Corporate Responsibility, Rhythm Pharmaceuticals, Inc. CR Report, Rhythm Pharmaceuticals, Inc. Citizenship Report, Rhythm Pharmaceuticals, Inc. ESG Report, and Rhythm Pharmaceuticals, Inc. Environmental Report online.